Featured Research

from universities, journals, and other organizations

Master Switch May Help Cancer Cells Hide From Immune System

Date:
January 11, 1999
Source:
Ohio State University
Summary:
A newly discovered gene mutation that works like a master switch may enable tumor cells to evade destruction by the immune system, new research shows.

COLUMBUS, Ohio -- A newly discovered gene mutation that works like a master switch may enable tumor cells to evade destruction by the immune system, new research shows.

Related Articles


The finding presents extraordinary possibilities for both cancer treatment and for organ transplantation. Turning the gene back on in cancer cells might one day allow physicians to make tumors more recognizable to the immune system -- and therefore more subject to destruction by the body.

Turning off the gene in tissue to be transplanted, on the other hand, might make the tissue less recognizable to the immune system and therefore less likely to be rejected by the body.

"It is very important to establish how human cancer evades being eliminated by the immune system," said Yang Liu, Kurtz Chair Professor of Pathology at Ohio State University's Comprehensive Cancer Center.

"If we know how a tumor evades the immune system, we can study how to deal with it. This could lead to a way to increase the immune system's sensitivity to the tumor."

At the same time, said Pan Zheng, assistant professor of pathology and Liu's coworker, "in transplantation, we might use the switch to decrease the sensitivity of immune recognition and make the transplant more successful."

The discovery, published in the November 26 issue of the journal Nature, was made in tumors implanted into mice.

The study identified a master gene that controls the primary means by which cells alert the immune system of a problem -- that the cell is infected by a virus or that it has become cancerous, for example.

The system works by taking fragments of materials produced inside the cell and displaying those fragments on the outside of the cell. This work is done by major histocompatibility complex type I (MHC-I) molecules.

MHC-I molecules are produced deep inside the cell and are then transported to the cell surface. During that journey, a piece of a different molecule from elsewhere in the cell is attached to it. The MHC-I molecule carries that fragment to the cell surface where the fragment sticks out on display.

In this way, a bit of every protein produced in cells ends up displayed on the cell's surface.

These displayed fragments are routinely "inspected" by immune cells known either as killer T-cells or cytotoxic lymphocytes (CTLs). CTLs patrol the body and check the surface of cells for the molecular fragments displayed by MHC molecules.

If the fragments are those of proteins that are normal to the body, the CTL continues on its way. But if the fragment comes from a foreign protein -- such as a protein produced by a virus or an abnormal protein produced by a cancer cell -- the CTL destroys the cell.

In many types of cancer, however, the MHC-I system is shut down in tumor cells. Until this study, researchers didn't know why or how the MHC-I system was turned off.

"Our findings provide a very attractive explanation for that observation," said Liu.

Liu, Zheng, and their colleagues have found a mutation that shuts down the MHC-I transport system, a mutation which blocks the normal production of a protein known as PML.

Furthermore, the researchers found that PML activates four other genes, all of which are needed by the MHC-I system. Blocking just one of these genes would be enough to inactivate the MHC-I system, said Liu, but the loss of PML affects all four genes.

"That suggests it might be a master gene," said Liu.

The PML protein has been known for a while, he said, but its function was not clear. "To find PML linked to these genes was a surprise."

Zheng and Liu are now investigating the mechanism by which PML controls the four genes, and how that correlates with the progression of cancer in human tumors.

Zheng is also determining how frequently the PML gene goes awry in human tumors. MHC-I down-regulation is already known to occur in 80 percent of human prostate cancers, the researchers said. The PML malfunction may also contribute to the tumor's ability to spread to other areas of the body (i.e., to metastasize).

This research was supported by grants from the National Institutes of Health, Kaplan Comprehensive Cancer Center of New York University Medical Center, and by the Ohio State University Comprehensive Cancer Center.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Master Switch May Help Cancer Cells Hide From Immune System." ScienceDaily. ScienceDaily, 11 January 1999. <www.sciencedaily.com/releases/1999/01/990111073718.htm>.
Ohio State University. (1999, January 11). Master Switch May Help Cancer Cells Hide From Immune System. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/1999/01/990111073718.htm
Ohio State University. "Master Switch May Help Cancer Cells Hide From Immune System." ScienceDaily. www.sciencedaily.com/releases/1999/01/990111073718.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins